Sakakura et al. used bisulfite-modified DNA and the real-time methylation-specific PCR of RUNX3 consisting of two steps of PCR to increase sensitivity for minute quantities of circulating tumor DNA, which resulted in a sensitivity of 0.0% (0/28) for stage I gastric cancer [24]. This evidence concerns the gene RUNX3 and gastric cancer.